Clinical Trial Update: BCAAs in Concussion 2.0 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating branched-chain amino acids for concussion and mild traumatic brain injury and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Concussion
• Traumatic Brain Injury

Drugs mentioned

• Branched-chain amino acids (BCAAs) (branched-chain amino acids)

Snippet

Sponsor: Akiva Cohen | Conditions: Concussion, Brain, Concussion, Mild | Phase 2 | Status: RECRUITING